FLAG-Foxo4 Citations (10)
Originally described in: Unpublished PlasmidsUnpublished
Articles Citing FLAG-Foxo4
| Articles |
|---|
| Increased proteasome activity in human embryonic stem cells is regulated by PSMD11. Vilchez D, Boyer L, Morantte I, Lutz M, Merkwirth C, Joyce D, Spencer B, Page L, Masliah E, Berggren WT, Gage FH, Dillin A. Nature. 2012 Sep 13;489(7415):304-8. doi: 10.1038/nature11468. PubMed |
| FoxO4 interacts with the sterol regulatory factor SREBP2 and the hypoxia inducible factor HIF2alpha at the CYP51 promoter. Zhu J, Jiang X, Chehab FF. J Lipid Res. 2014 Mar;55(3):431-42. doi: 10.1194/jlr.M043521. Epub 2013 Dec 18. PubMed |
| SIRT1 and FOXO Mediate Contractile Differentiation of Vascular Smooth Muscle Cells under Cyclic Stretch. Huang K, Yan ZQ, Zhao D, Chen SG, Gao LZ, Zhang P, Shen BR, Han HC, Qi YX, Jiang ZL. Cell Physiol Biochem. 2015;37(5):1817-29. doi: 10.1159/000438544. Epub 2015 Nov 13. PubMed |
| FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma. Ryu KJ, Park C, Hong M, Ko YH, Kim WS, Kim SJ. Oncotarget. 2017 Jan 10;8(2):2466-2476. doi: 10.18632/oncotarget.13690. PubMed |
| FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression. Gopal K, Saleme B, Al Batran R, Aburasayn H, Eshreif A, Ho KL, Ma WK, Almutairi M, Eaton F, Gandhi M, Park EA, Sutendra G, Ussher JR. Am J Physiol Heart Circ Physiol. 2017 Jul 7:ajpheart.00191.2017. doi: 10.1152/ajpheart.00191.2017. PubMed |
| Oncogenic RAS-induced CK1alpha drives nuclear FOXO proteolysis. Zhang F, Virshup DM, Cheong JK. Oncogene. 2018 Jan 18;37(3):363-376. doi: 10.1038/onc.2017.334. Epub 2017 Sep 25. PubMed |
| Unspliced XBP1 Confers VSMC Homeostasis and Prevents Aortic Aneurysm Formation via FoxO4 Interaction. Zhao G, Fu Y, Cai Z, Yu F, Gong Z, Dai R, Hu Y, Zeng L, Xu Q, Kong W. Circ Res. 2017 Dec 8;121(12):1331-1345. doi: 10.1161/CIRCRESAHA.117.311450. Epub 2017 Oct 31. PubMed |
| A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma. Salcher S, Spoden G, Hagenbuchner J, Fuhrer S, Kaserer T, Tollinger M, Huber-Cantonati P, Gruber T, Schuster D, Gust R, Zwierzina H, Muller T, Kiechl-Kohlendorfer U, Ausserlechner MJ, Obexer P. Oncogene. 2020 Jan;39(5):1080-1097. doi: 10.1038/s41388-019-1044-7. Epub 2019 Oct 7. PubMed |
| Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation In Vitro via Induction of G0/G1 Arrest. Intuyod K, Chomwong S, Thongpon P, Vaeteewoottacharn K, Pairojkul C, Pinlaor P, Pinlaor S. Anticancer Res. 2020 Dec;40(12):6899-6905. doi: 10.21873/anticanres.14713. PubMed |
| FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity. Lee SH, Jung S, Lee YJ, Hyun M, Chung KC. J Biol Chem. 2021 Dec;297(6):101426. doi: 10.1016/j.jbc.2021.101426. Epub 2021 Nov 17. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.